Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0SX7F
|
||||
Former ID |
DNC013055
|
||||
Drug Name |
AZALANSTAT
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Hyperlipidaemia [ICD9: 272.0-272.4; ICD10:E78] | Discontinued in Phase 2 | [545151] | ||
Structure |
Download2D MOL |
||||
Formula |
C22H24ClN3O2S
|
||||
Canonical SMILES |
C1C(OC(O1)(CCC2=CC=C(C=C2)Cl)CN3C=CN=C3)CSC4=CC=C(C=C4)<br />N
|
||||
InChI |
1S/C22H24ClN3O2S/c23-18-3-1-17(2-4-18)9-10-22(15-26-12-11-25-16-26)27-13-20(28-22)14-29-21-7-5-19(24)6-8-21/h1-8,11-12,16,20H,9-10,13-15,24H2/t20-,22-/m0/s1
|
||||
InChIKey |
VYNIUBZKEWJOJP-UNMCSNQZSA-N
|
||||
CAS Number |
CAS 143484-82-6
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fungal Cytochrome P450 51 | Target Info | Modulator | ||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.